- Business Wire•1 hour ago
Pivotal Phase III Study Underscores Efficacy Of Zavicefta™ (ceftazidime-avibactam) For Treatment Of Hospital-Acquired Pneumonia, A Leading Cause Of Mortality In Hospitals
Positive results of the REPROVE1 Study showed that patients diagnosed with hospital-acquired pneumonia , treated with Zavicefta, a novel combination antibiotic for the treatment of certain known or suspected Gram-negative bacterial infections, or Meropenem , a broad spectrum carbapenem antibiotic currently considered the standard of care, experienced comparable rates of clinical cure at test-of-cure ...
- TheStreet.com•13 hours ago
The Trump administration's executive order on tax regulations could revive the defunct Allergan-Pfizer merger.
PFE : Summary for Pfizer, Inc. - Yahoo Finance
Pfizer Inc. (PFE)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||33.47 - 33.73|
|52 Week Range||29.83 - 37.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||28.68|
|Dividend & Yield||1.28 (3.76%)|
|1y Target Est||N/A|